Le Lézard
Classified in: Health, Business
Subjects: ERN, CPG, MAT

Net income of $33 million for the SQDC's third quarter


MONTRÉAL, Feb. 14, 2024 /CNW/ - The Société québécoise du cannabis (SQDC) has reported comprehensive income of $33 million for the third quarter of its 2023-2024 fiscal year, which ended December 30, 2023. The amount is remitted in full to the Québec government and reinvested primarily in cannabis-related prevention efforts and research.

To that figure can be added business-related tax revenues in the form of consumer and excise taxes, estimated at $61.4 million ($43.5 million to the Québec government and $17.9 million to the federal government). In all, $94.4 million is being paid to the two governments, $76.5 million of which is destined for the Québec treasury.

Quarterly results at a glance
Highlights of the quarter

The interim financial report for the quarter running from September 10 to December 30, 2023, is now available (in French only) on SQDC.ca

About the Société québécoise du cannabis (SQDC)

The SQDC is a government corporation mandated to distribute and sell cannabis in Québec with a focus on protecting customers' health and safety. The company is committed to offering quality products and informing and advising consumers on how to minimize the health impacts of cannabis. The long-term objective is to shrink the illegal cannabis market in Québec. By law, all the SQDC's profits are remitted to the Fonds de lutte contre les dépendances, a fund managed by the Ministère des Finances du Québec, and reinvested primarily in cannabis-related education, prevention efforts and research. For more information, visit SQDC.ca.

SOURCE Société québécoise du cannabis


These press releases may also interest you

at 20:05
CUPID is a Phase I safety and dosimetry study of TLX592, Telix's investigational antibody-based targeted alpha therapy for prostate cancer.Establishes proof-of-concept for Telix's proprietary RADmAb® engineered antibody platform, currently under...

at 19:42
The shareholders in Immunovia AB (publ), Reg. No. 556730-4299, are hereby invited to the Annual General Meeting ("AGM") to be held at The Spark, Scheeletorget 1, Medicon Village, in Lund on Wednesday 19 June 2024 at 10 a.m. CEST. Right to...

at 18:54
The Board of Directors of Immunovia AB (publ) ("Immunovia" or the "Company") has today,...

at 18:12
The global functional food ingredients market size is estimated to grow by USD 53.14 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 7.38% during the forecast period. ...

at 17:55
City of Hope®, one of the largest cancer research and treatment organizations in the United States, has been awarded $5.4 million from the California Institute for Regenerative Medicine (CIRM) to build and fund a stem cell research laboratory on its...

at 17:25
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...



News published on and distributed by: